» Authors » Anup Srivastav

Anup Srivastav

Explore the profile of Anup Srivastav including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 989
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Santibanez T, Black C, Zhou T, Srivastav A, Singleton J
Vaccine . 2024 Jul; 42(25):126139. PMID: 39019662
Background: Some public health professionals have expressed concern that the COVID-19 pandemic has increased vaccine hesitancy about routine childhood vaccines; however, the differential prevalence of vaccine hesitancy about specific vaccines...
2.
Srivastav A, Lu P, Amaya A, Dever J, Stanley M, Franks J, et al.
Vaccine . 2023 Mar; 41(15):2572-2581. PMID: 36907734
Background: The role of vaccine hesitancy on influenza vaccination is not clearly understood. Low influenza vaccination coverage in U.S. adults suggests that a multitude of factors may be responsible for...
3.
Meghani M, Razzaghi H, Kahn K, Hung M, Srivastav A, Lu P, et al.
J Womens Health (Larchmt) . 2023 Mar; 32(3):260-270. PMID: 36884385
Pregnant women* and their infants are at increased risk for serious influenza, pertussis, and COVID-19-related complications, including preterm birth, low-birth weight, and maternal and fetal death. The advisory committee on...
4.
de Perio M, Srivastav A, Razzaghi H, Laney A, Black C
Am J Prev Med . 2023 Mar; 65(3):521-527. PMID: 36878415
Introduction: Healthcare personnel are at risk for acquiring and transmitting respiratory infections in the workplace. Paid sick leave benefits allow workers to stay home and visit a healthcare provider when...
5.
Lu P, Zhou T, Santibanez T, Jain A, Black C, Srivastav A, et al.
MMWR Morb Mortal Wkly Rep . 2023 Feb; 72(7):190-198. PMID: 36795677
COVID-19 vaccine booster doses are safe and maintain protection after receipt of a primary vaccination series and reduce the risk for serious COVID-19-related outcomes, including emergency department visits, hospitalization, and...
6.
Lu P, Srivastav A, Vashist K, Black C, Kriss J, Hung M, et al.
Emerg Infect Dis . 2022 Dec; 29(1):133-140. PMID: 36480674
The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey-Adult COVID Module...
7.
Black C, OHalloran A, Hung M, Srivastav A, Lu P, Garg S, et al.
MMWR Morb Mortal Wkly Rep . 2022 Oct; 71(43):1366-1373. PMID: 36302226
Introduction: CDC estimates that influenza resulted in 9-41 million illnesses, 140,000-710,000 hospitalizations, and 12,000-52,000 deaths annually during 2010-2020. Persons from some racial and ethnic minority groups have historically experienced higher...
8.
Razzaghi H, Srivastav A, de Perio M, Laney A, Black C
MMWR Morb Mortal Wkly Rep . 2022 Oct; 71(42):1319-1326. PMID: 36264832
The Advisory Committee on Immunization Practices (ACIP) and CDC recommend that all health care personnel (HCP) receive annual influenza vaccination to reduce influenza-related morbidity and mortality among these personnel and...
9.
Dever J, Amaya A, Srivastav A, Lu P, Roycroft J, Stanley M, et al.
J Surv Stat Methodol . 2022 Sep; 9(3):449-476. PMID: 36060551
Researchers strive to design and implement high-quality surveys to maximize the utility of the data collected. The definitions of quality and usefulness, however, vary from survey to survey and depend...
10.
Stanley M, Roycroft J, Amaya A, Dever J, Srivastav A
Field methods . 2022 Aug; 32(2):159-179. PMID: 35923434
Previous research has shown that increasing the size of incentives can increase response rates for probability-based, cross-sectional surveys. However, the effects of incentives on web panels have not been extensively...